Analysts expect Envision's Q1 earnings of $0.51 EPS — 4 insights

Oppenheimer issued a new reported on Envision Healthcare, predicting first quarter 2018 earnings of $0.51 per share, Stock News Times reports.

Here's what you should know:

1. Oppenheimer revised its predictions from the initial $0.49 per share.

2. In addition, Oppenheimer gave Envision an "outperform" rating and a $40 price target on the stock.

3. Several other analysts published predictions, as well. Robert Baird reissued its "buy" rating, with a price target of $55. Bank of America decreased their target from $72 to $60 while also setting a “buy” rating on the stock.

4. In total, nine companies issued a "buy" rating, eight a "hold" rating and one a "sell" rating. The consensus is a "hold" rating, and a price target of $41.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast